GlaxoSmithKline Plc, the U.K.’s largest drugmaker, said third-quarter profit was little changed, held back by lower sales of the Avandia... ...
http://www.businessweek.com/news/2011-10-26/glaxo-profit-little-changed-as-avandia-valtrex-sales-fall.htmlThe UK online clinic 121doc has agreed to add GlaxoSmithKline drug Valtrex, a prescription only medication (POM) to its list of treatments. The... ...
http://www.prweb.com/releases/2011/10/prweb8890407.htmEmkay has downgraded Ranbaxy Laboratories to `Reduce` with a price target of Rs 424 as against the current market price (CMP) of Rs 534 in its... ...
http://feedproxy.google.com/~r/Myiris/~3/bYSMPm_CXM4/storyShow.phpGlaxoSmithKline Plc reported a third straight drop in quarterly revenue on lower sales of the Avandia diabetes drug, the Valtrex antiviral and... ...
http://www.businessweek.com/news/2011-07-26/glaxo-sales-drop-as-avandia-valtrex-flu-products-decline.htmlBroking firm Sharekhan maintain its positive stance on pharmaceutical (pharma) companies under its coverage that have exposure to US generics... ...
http://www.myiris.com/newsCentre/storyShow.php?fileR=20110106115117043&dir=2011/01/06&source=rss